Italy: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Italy

The Italian prophylactic medicaments containing insulin market surged to $X in 2022, with an increase of X% against the previous year. Overall, consumption, however, continues to indicate a abrupt curtailment. Prophylactic medicaments containing insulin consumption peaked at $X in 2015; however, from 2016 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Italy

In value terms, prophylactic medicaments containing insulin production expanded modestly to $X in 2022 estimated in export price. Overall, production continues to indicate prominent growth. The most prominent rate of growth was recorded in 2013 when the production volume increased by X%. Over the period under review, production attained the peak level at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Italy

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the third year in a row after two years of decline. Over the period under review, total exports indicated a buoyant expansion from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2019 indices. The pace of growth appeared the most rapid in 2013 with an increase of X% against the previous year. Over the period under review, the exports reached the maximum at X tons in 2017; however, from 2018 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports expanded modestly to $X in 2022. In general, exports continue to indicate a prominent increase. The most prominent rate of growth was recorded in 2017 when exports increased by X%. The exports peaked at $X in 2020; however, from 2021 to 2022, the exports failed to regain momentum.

Exports by Country

France (X tons) was the main destination for prophylactic medicaments containing insulin exports from Italy, accounting for a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to France exceeded the volume sent to the second major destination, China (X tons), threefold. Germany (X tons) ranked third in terms of total exports with an X% share.

From 2012 to 2022, the average annual growth rate of volume to France stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (X% per year) and Germany (X% per year).

In value terms, France ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Italy, comprising X% of total exports. The second position in the ranking was taken by China ($X), with an X% share of total exports. It was followed by Germany, with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to France amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (X% per year) and Germany (X% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, flattening at the previous year. Over the period under review, the export price recorded a slight setback. The pace of growth appeared the most rapid in 2017 an increase of X% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2020; however, from 2021 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while the average price for exports to the United States ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the Czech Republic (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Italy

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported into Italy; growing by X% on the previous year's figure. In general, imports, however, saw a perceptible decline. Over the period under review, imports hit record highs at X tons in 2012; however, from 2013 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports soared to $X in 2022. Overall, imports, however, showed a deep contraction. Imports peaked at $X in 2012; however, from 2013 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, France (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Italy, with a X% share of total imports. Moreover, prophylactic medicaments containing insulin imports from France exceeded the figures recorded by the second-largest supplier, China (X tons), fourfold. Turkey (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from France totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: China (X.7% per year) and Turkey (X% per year).

In value terms, the largest prophylactic medicaments containing insulin suppliers to Italy were France ($X), China ($X) and Turkey ($X), with a combined X% share of total imports.

In terms of the main suppliers, China, with a CAGR of X.9%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, surging by X% against the previous year. Over the period under review, the import price, however, saw a slight decline. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was China ($X per ton), while the price for Turkey ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :